Clinical Trial Update: AMX0035 in Adult Patients With Wolfram Syndrome [Phase 2]

View source ↗

Summary

AMX0035 is being studied in a Phase 2 trial for adult patients with Wolfram syndrome, and the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wolfram Syndrome

Drugs mentioned

• AMX0035 (sodium phenylbutyrate and tauroursodeoxycholic acid)

Snippet

Sponsor: Amylyx Pharmaceuticals Inc. | Conditions: Wolfram Syndrome | Phase 2 | Status: ACTIVE_NOT_RECRUITING